Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Minyoung Kim, M.D., Ph.D
Woman and Man Max 99 years
Minyoung Kim, M.D., Ph.D
Update Il y a 4 ans
FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy
This is randomized placebo-controlled trial to recognize new cell regeneration in the brain using FLT-PET.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Minyoung Kim, M.D., Ph.D
Update Il y a 4 ans
Allogeneic Umbilical Cord Blood Therapy for Chronic TBI
This open label trial is conducted to investigate the efficacy and safety of umbilical cord blood therapy for chronic traumatic brain injury patients. The study hypothesis is that the par...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Minyoung Kim, M.D., Ph.D
Update Il y a 4 ans
Umbilical Cord Blood Therapy for Cerebral Palsy
This randomized controlled study aims to evaluate the efficacy of umbilical cord blood therapy for children with cerebral palsy.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Minyoung Kim, M.D., Ph.D
Update Il y a 4 ans
Umbilical Cord Blood Therapy for Children With Global Developmental Delay
This open-label study aims to evaluate the safety and efficacy of umbilical cord blood therapy for children with global developmental delay.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Minyoung Kim, M.D., Ph.D
Update Il y a 4 ans
Erythropoietin Therapy for Children With Cerebral Palsy
This randomized placebo-controlled trial aims to investigate the efficacy and safety of erythropoetin for children with cerebral palsy.
Country
Korea, Republic of
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Minyoung Kim, M.D., Ph.D
Update Il y a 4 ans
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1
This purpose of this phase 1 study is to investigate the safety and efficacy of erythropoetin for children with cerebral palsy.
Country
Korea, Republic of
organs
None
Specialty
None
Closed trial
More information